ORGS Stock UPDATES Orgenesis Inc (ORGS) 0.5520 08/25/2014 11

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orgenesis Inc (ORGS) 0.5520 $ORGS

Scott Carmer Named as CEO of Orgenesis North America
Marketwire - Mon Aug 04, 8:03AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of industry veteran Scott Carmer as CEO of the company's North American subsidiary. Carmer has more than 25 years of diverse industry experience within both pharmaceutical and biotech companies.

Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
Marketwire - Mon Jul 07, 7:40AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian subsidiary, Orgenesis SPRL, has signed a strategic agreement with MaSTherCell SA of Gosselies, Belgium. Orgenesis believes that the agreement will enable Orgenesis to advance its manufacturing (GMP) process from lab scale to clinical scale as it prepares for Phase I and Phase II clinical trials.

Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
Marketwire - Wed Jun 25, 7:31AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5 million via a senior secured term loan facility.

Orgenesis Secures $3 Million in Funding From Kodiak Capital Group
Marketwire - Wed Dec 18, 10:02AM CST
Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver cells into functioning insulin-producing cells, has entered into a $3 million common stock purchase agreement with Kodiak Capital Group LLC, a Newport Beach, Calif.-based institutional investor.

Orgenesis to Present at the 2013 Gateway Conference on September 10
Marketwire - Wed Sep 04, 4:16PM CDT
Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, has been invited to present at the 2013 Gateway Conference being held on Tuesday, September 10, 2013 at the Palace Hotel in San Francisco.

Dr. David Sidransky Appointed to Orgenesis' Board of Directors
GlobeNewswire - Thu Jul 18, 1:00PM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce the appointment of Dr. David Sidransky, Professor and Director of the Head and Neck Cancer Research Division at the Johns Hopkins University School of Medicine's Department of Otolaryngology, to its Board of Directors.

Orgenesis to Present Updates at Two Key June Conferences
GlobeNewswire - Thu May 30, 1:30PM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that it will be presenting updates on the Company's business and technology at two key conferences in the month of June.

Orgenesis and ATMI Enter Into Process Development Agreement
GlobeNewswire - Thu May 09, 6:55AM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today that its wholly owned subsidiary, Orgenesis Ltd., has entered into a process development agreement (the "PD Agreement" with ATMI, Inc. (Nasdaq:ATMI), a global technology company and leader in single-use bioprocess solutions.

Leading Diabetes Expert, Jay S. Skyler, M.D., Joins Orgenesis' Scientific Advisory Board
GlobeNewswire - Thu Apr 11, 7:15AM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce the appointment of Jay S. Skyler, M.D., to its Scientific Advisory Board.

Orgenesis to Present at ATTD 2013
GlobeNewswire - Wed Feb 20, 1:11PM CST
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that its Chief Science Officer, Prof. Sarah Ferber, is scheduled to present at the 6 International Conference on Advanced Technologies & Treatments for Diabetes, to be held February 27 - March 3, 2013 in Paris, France.

Orgenesis Announces Management Changes
GlobeNewswire - Mon Jan 07, 7:00AM CST
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today the appointment of Sav DiPasquale as President and Chief Executive Officer. Mr. DiPasquale succeeds Jacob BenArie, who has been appointed Chief Executive Officer of the Company's private subsidiary, Orgenesis Ltd.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FuelCell Energy Faces Legal Scrutiny After Stock Plunge

Updated Category News Views 14

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Continue Reading
BioMarin Strikes Deal for New Fabry Disease Therapy

Updated Category News Views 25

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

Continue Reading
BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Updated Category News Views 24

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

Continue Reading
Universal Music Hits High Note with 11% Revenue Surge

Updated Category News Views 35

Universal's Harmonious Growth in 2026 Universal Music Group (UMG) isn't just playing second fiddle to anyone in the music biz. They've rolled out an impressive set of numbers for Q3 2026. We're talking €3,394 million in revenue, marking a solid 12.3% bump year-over-year, or 11.7% when the currency takes a breather. Hats off to the acquisition of Downtown, which greased...

Continue Reading
AI Identity Fraud Forces New Screening Tactics in Hiring

Updated Category News Views 9

AI and Identity Fraud: A New Hiring Challenge Piling up futuristic gadgets and tech has made hiring more like a cat and mouse game lately. You'd think checking someone's background would shut the case, but tech-savvy fraudsters have other plans. Employers are up against AI-generated shenanigans and identity theft that are making the business of verifying who exactly...

Continue Reading
Celebrate Dr. David Neff's Healthcare Legacy

Updated Category News Views 107

An Icon in Medicine and Innovation Dr. David R. Neff's recognition as a Pinnacle Lifetime Member marks a storied journey through medicine and healthcare innovation. Decades of Dedication to Patient Care For over 45 years, Neff carved out a niche in medicine that few can parallel. His overarching focus on infectious disease, cancer, and more represents a holistic approach...

Continue Reading
Instacart's Strong Q3 Amid DoorDash Acquisition News

Updated Category News Views 54

Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...

Continue Reading
FFR Goes Global with Binance Stock Offering

Updated Category News Views 13

FFR Stock Hits the International Stage Here's something that's sure to rattle a few cages in the world of robotics and international trading. FF EAI Robotics Ecosystem Inc. (NASDAQ:FFR) has just opened up their stock to the global stage via Binance's U.S. stock trading service. For those outside the 'land of the free,' this means eligible investors can now get their hands...

Continue Reading
Birth Injury Lawsuit Secures $19.1M Award in Michigan

Updated Category News Views 0

Legal Triumph for Sokolove's Birth Injury Case There are days when you see a win in the courtroom and think maybe, just maybe, justice ain't just a fairytale. Today, that thought knocks heavier with news rolling out of Michigan—an astronomical $19.1 million awarded to a family by a federal judge after a botched birth led to lifelong medical issues. You've got Sokolove...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 132

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading

Top 5 Most Recently Viewed Articles

Sable Offshore Corp. Investors: Important Action Required Now

Updated Category News Views 184

Important Action for Sable Offshore Corp. Investors Recent developments have raised significant concerns for investors of Sable Offshore Corp. Understanding the implications of a class action lawsuit is crucial to your financial well-being. Details on the Class Action Lawsuit Rosen Law Firm has initiated a class action lawsuit on behalf of Sable Offshore Corp. investors...

Continue Reading
Investor Deadlines for Lantheus, VFC, and Fluor Explained

Updated Category News Views 151

Important Deadlines for Investors in Lantheus, VFC, and Fluor In the realm of shareholder rights, it’s crucial for investors to stay informed about significant legal actions that may impact their investments. Recently, class actions have been initiated concerning Lantheus Holdings, Inc. (NASDAQ: LNTH), V.F. Corporation (NYSE: VFC), and Fluor Corporation (NYSE: FLR)....

Continue Reading
Spotify's Expansion and Profitability Challenges: A Closer Look

Updated Category News Views 187

Spotify Sees Growth Amid Profitability Worries Spotify Technology (NYSE: SPOT) recently reported a notable fluctuation in its stock performance, linked closely to the release of its recent financial results. While the renowned audio streaming platform showcased impressive growth in its user base, it was met with skepticism from investors due to a significant miss in...

Continue Reading
Danone and NGOs Reach a Solid Agreement on Plastic Strategy

Updated Category News Views 307

Danone and Non-Governmental Organizations Unite for Action In a positive development for environmental sustainability, Danone has successfully concluded legal proceedings with NGOs ClientEarth, Surfrider Foundation Europe, and Zero Waste France. This resolution marks a significant moment in Danone's commitment to improving its plastic management strategies. Agreement for...

Continue Reading
Otis Worldwide Corporation Shares Strong Second Quarter Results

Updated Category News Views 148

Otis Worldwide Corporation Reports Upbeat Second Quarter Results Otis Worldwide Corporation has announced its second quarter results for the year 2025, reflecting notable performance metrics that have continued to build momentum in the company’s service offerings. The quarter revealed an impressive organic service sales growth of 4%, while total service net sales surged...

Continue Reading